Table 2 Baseline outcome scores
Health measures | n | Intervention participants | n | Control participants | Test statistic; p-value |
|---|---|---|---|---|---|
SF-12 MCS - mean (SD) | 197 | 43.2 (11.0) | 195 | 49.6 (9.8) | 6.1; p < 0.001a |
SF-12 PCS - mean (SD) | 197 | 34.7 (11.7) | 195 | 42.8 (12.5) | 6.6; p < 0.001a |
EQ-5D - mean (SD) | 198 | 0.5 (0.3) | 194 | 0.7 (0.3) | 7.5; p < 0.001a |
GDS-10 - mean (SD) | 195 | 4.4 (2.4) | 192 | 2.2 (2.2) | -9.3; p < 0.001a |
Social support | n | Â | n | Â | Test statistic; p-value |
MOS-6 - mean (SD) | 199 | 2.7 (1.1) | 193 | 3.5 (1.0) | 8.3; p < 0.001a |
Social activities | n | Â | n | Â | Test statistic; p-value |
No. friends/family - median (IQR) | 200 | 5 (2, 10) | 193 | 5 (3, 10) | 0.9; p = 0.38a |
No. clubs/groups - median (IQR) | 199 | 1 (0, 2) | 194 | 1 (0, 2) | 1.4; p = 0.15a |
Get together with friends/family - n (%) | 199 | Â | 194 | Â | -0.9; p = 0.36b |
Every day | Â | 14 (7.0%) | Â | 16 (8.3%) | Â |
Several days a week | Â | 51 (25.6%) | Â | 50 (25.8%) | Â |
Once a week | Â | 52 (26.1%) | Â | 49 (25.3%) | Â |
2-3 times a month | Â | 24 (12.1%) | Â | 30 (15.5%) | Â |
Once a month | Â | 16 (8.0%) | Â | 24 (12.4%) | Â |
5-10 times a year | Â | 11 (5.5%) | Â | 14 (7.2%) | Â |
Less than 5 times a year | Â | 31 (15.6%) | Â | 11 (5.7%) | Â |
Getting along with others - n (%) | 200 | Â | 194 | Â | -1.6; p = 0.11b |
Better | Â | 17 (8.5%) | Â | 16 (8.3%) | Â |
The same | Â | 154 (77.0%) | Â | 164 (84.5%) | Â |
Worse | Â | 29 (14.5%) | Â | 14 (7.2%) | Â |
GHS items | n | Â | n | Â | Test statistic; p-value |
Work around the house - n (%) | 200 | 16 (8.0%) | 195 | 36 (18.5%) | 9.5; p < 0.01c |
Transport/errands - n (%) | 200 | 27 (13.5%) | 195 | 59 (30.3%) | 16.3; p < 0.001c |
Child care - n (%) | 200 | 21 (10.5%) | 195 | 37 (19.0%) | 5.7; p < 0.05c |
Practical advice - n (%) | 200 | 24 (12.0%) | 195 | 37 (19.0%) | 3.7; p = 0.06c |
Emotional support - n (%) | 200 | 48 (24.0%) | 195 | 103 (52.8%) | 34.7; p < 0.001c |
Other - n (%) | 200 | 26 (13.0%) | 195 | 38 (19.5%) | 3.1; p = 0.08c |
None of the above - n (%) | 200 | 107 (53.5%) | 195 | 55 (28.2%) | 26.1; p < 0.001c |
Morbidity | n | Â | n | Â | Test statistic; p-value |
Angina - n (%) | 200 | 30 (15.0%) | 195 | 14 (7.2%) | 6.1; p < 0.05c |
Arthritis - n (%) | 200 | 92 (46.0%) | 195 | 90 (46.2%) | 0.001; p = 1.0c |
Cancer - n (%) | 200 | 15 (7.5%) | 195 | 10 (5.1%) | 0.9; p = 0.33c |
Diabetes - n (%) | 200 | 28 (14.0%) | 195 | 17 (8.7%) | 2.7; p = 0.10c |
Heart failure - n (%) | 200 | 17 (8.5%) | 194 | 4 (2.1%) | 8.1; p < 0.01c |
High blood pressure - n (%) | 199 | 98 (49.3%) | 195 | 78 (40.0%) | 3.4; p = 0.07c |
Sight/hearing problems - n (%) | 200 | 114 (57.0%) | 195 | 73 (37.4%) | 15.2; p < 0.001c |
Stroke - n (%) | 199 | 13 (6.5%) | 195 | 2 (1.0%) | 8.2; p < 0.01c |
Depression or anxiety - n (%) | 200 | 127 (63.5%) | 195 | 66 (33.9%) | 34.7; p < 0.001c |
Memory/concentration problems - n (%) | 200 | 121 (60.5%) | 195 | 79 (40.5%) | 15.8; p < 0.001c |
Chronic respiratory conditions - n (%) | 200 | 39 (19.5%) | 195 | 30 (15.4%) | 1.2; p = 0.28c |
Sleeping difficulties - n (%) | 200 | 120 (60.0%) | 195 | 87 (44.6%) | 9.4; p < 0.01c |